TrialThe oncologist2025

Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide.

Bo Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.